heart disease

After clearing out heart disease drug, Arrowhead maps out obesity development plans
Fierce Biotech
Wed, 08/14/24 - 10:41 pm
Arrowhead Pharmaceuticals
RNAi
R&D
obesity
heart disease
Novo Nordisk's Wegovy gets UK approval for lowering heart risks
Reuters
Tue, 07/23/24 - 11:24 am
Novo Nordisk
UK
Wegovy
heart disease
stroke
obesity
Cardurion raises another $260M to fuel heart drug pipeline
BioPharma Dive
Tue, 07/16/24 - 11:14 pm
Cardurion
funding
heart disease
Added health benefits of Wegovy, Zepbound could attract more men, doctors say
Reuters
Mon, 06/10/24 - 11:15 am
Novo Nordisk
Wegovy
Eli Lilly
Zepbound
men's health
sleep apnea
heart disease
Cytokinetics shows hand in high stakes rivalry with BMS' Camzyos
Fierce Biotech
Mon, 05/13/24 - 11:08 am
Cytokinetics
Bristol Myers Squibb
Camzyos
aficamten
heart disease
Verve moves forward with backup base editing therapy
BioPharma Dive
Tue, 05/7/24 - 11:29 am
Verve Therapeutics
clinical trials
gene therapy
heart disease
Drugs Like Ozempic And Mounjaro Could Treat Other Conditions—Here’s What Scientists Are Looking At
Forbes
Thu, 04/18/24 - 10:25 pm
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Zepbound
Mounjaro
anxiety
addiction
heart disease
liver disease
Novo’s $1.1B Cardior buy continues expansion into heart disease
BioSpace
Mon, 03/25/24 - 11:39 am
Novo Nordisk
Cardior Pharmaceuticals
M&A
heart disease
Medicare to cover Novo’s weight-loss drug Wegovy for patients with heart disease
BioSpace
Fri, 03/22/24 - 10:58 am
Medicare
Novo Nordisk
weight loss
Wegovy
heart disease
Novo Nordisk says Wegovy can help heart disease patients—and not just because it produces weight loss
Fierce Pharma
Mon, 11/13/23 - 12:08 pm
Novo Nordisk
Wegovy
heart disease
cardiovascular disease
clinical trials
First look at Verve study data offer base editing ‘proof of principle’
BioPharma Dive
Sun, 11/12/23 - 09:27 pm
Verve Therapeutics
heart disease
gene editing
Verve gets FDA green light to run base editing study in US
BioPharma Dive
Mon, 10/23/23 - 05:01 pm
Verve Therapeutics
FDA
gene editing
heart disease
clinical trials
Pfizer Lawsuit Seeks to Block Generic Copy of Heart Disease Blockbuster
BioSpace
Mon, 08/14/23 - 06:47 pm
Pfizer
generics
legal
Vyndamax
heart disease
patents
tafamidis
Dexcel Pharma
Evox Therapeutics to advance gene therapy for treatment of heart disease
Biopharma Reporter
Mon, 08/7/23 - 10:46 am
Evox Therapeutics
gene therapy
Mount Sinai
heart disease
cardiomyocytes
Agepha Pharma gets ancient gout remedy colchicine across FDA finish line for heart disease
Fierce Pharma
Tue, 06/20/23 - 09:35 pm
Agepha Pharma
FDA
colchicine
heart disease
Lodoco
Verve partners with Lilly on gene editing therapy for heart disease
BioPharma Dive
Thu, 06/15/23 - 10:02 am
Eli Lilly
Verve Therapeutics
heart disease
gene editing
XyloCor wraps up PhII for heart disease gene therapy, plans for pivotal trial
Endpoints
Fri, 01/27/23 - 10:31 am
XyloCor Therapeutics
gene therapy
heart disease
clinical trials
Study: Base Editing Shows Promise In Treating Heart Disease
BioSpace
Tue, 01/17/23 - 10:28 am
gene editing
base editing
heart disease
heart damage
Could Amgen's Heart Disease Candidate Generate Billions in Sales?
Motley Fool
Sun, 12/11/22 - 01:26 pm
Amgen
heart disease
olpasiran
Arrowhead Gets $250M in Royalty Deal for Cardio Drug Heading to Phase 3
MedCity News
Wed, 11/9/22 - 11:30 pm
Amgen
Arrowhead Pharmaceuticals
olpasiran
heart disease

Pages